Analysts Offer Insights on Healthcare Companies: Endologix Inc (NASDAQ: ELGX), Shire (NASDAQ: SHPG) and Community Health (NYSE: CYH)

By Austin Angelo

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Endologix Inc (NASDAQ: ELGX), Shire (NASDAQ: SHPG) and Community Health (NYSE: CYH).

Endologix Inc (NASDAQ: ELGX)

In a report released yesterday, Glenn Novarro from RBC Capital reiterated a Hold rating on Endologix Inc (NASDAQ: ELGX), with a price target of $5. The company’s shares closed yesterday at $4.26, close to its 52-week low of $4.21.

According to TipRanks.com, Novarro is a top 100 analyst with an average return of 12.5% and a 82.9% success rate. Novarro covers the Healthcare sector, focusing on stocks such as Integer Holdings Corporation, Boston Scientific Corp, and Varian Medical Systems.

Currently, the analyst consensus on Endologix Inc is Hold and the average price target is $5.92, representing a 39.0% upside.

In a report released yesterday, Stephens also downgraded the stock to Hold with a $6 price target.
Shire (NASDAQ: SHPG)

RBC Capital analyst Douglas Miehm reiterated a Buy rating on Shire (NASDAQ: SHPG) yesterday and set a price target of $221. The company’s shares closed yesterday at $190.

According to TipRanks.com, Miehm is ranked 0 out of 5 stars with an average return of -10.0% and a 38.6% success rate. Miehm covers the Healthcare sector, focusing on stocks such as Novelion Therapeutics Inc, Cardiome Pharma Corp, and Concordia Healthcare.

Shire has an analyst consensus of Strong Buy, with a price target consensus of $236.67.

Community Health (NYSE: CYH)

In a report released yesterday, Frank Morgan from RBC Capital reiterated a Hold rating on Community Health (NYSE: CYH), with a price target of $10. The company’s shares closed yesterday at $9.37.

According to TipRanks.com, Morgan is a 5-star analyst with an average return of 12.5% and a 63.5% success rate. Morgan covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care Corp, Quest Diagnostics Inc, and Surgery Partners Inc.

Currently, the analyst consensus on Community Health is Hold and the average price target is $9.56, representing a 2.0% upside.

In a report issued on May 3, Cantor Fitzgerald also reiterated a Hold rating on the stock with a $9 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.